PMC:7205724 / 107-322
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 145-152 | Species | denotes | patient | Tax:9606 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 25-40 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 46-61 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T3 | 114-129 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T4 | 177-192 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T1 | 25-40 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulins | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 46-61 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T2 | 114-129 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T3 | 177-192 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 8-61 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
T4 | 63-73 | Sentence | denotes | Highlights |
T5 | 74-162 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
3 | 145-152 | Species | denotes | patient | Tax:9606 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 0-6 | NNS | denotes | agents |
T16 | 6-7 | -COLON- | denotes | : |
T17 | 8-23 | NNS | denotes | Anti-antibodies |
T18 | 23-24 | -COMMA- | denotes | , |
T19 | 25-40 | NNS | denotes | immunoglobulins |
T20 | 40-41 | -COMMA- | denotes | , |
T21 | 42-45 | CC | denotes | and |
T22 | 46-61 | NNS | denotes | corticosteroids |
T23 | 63-73 | NNS | denotes | Highlights |
T24 | 74-75 | IN | denotes | • |
T25 | 77-81 | NNP | denotes | IVIG |
T26 | 81-82 | -COMMA- | denotes | , |
T27 | 83-91 | VBN | denotes | combined |
T28 | 92-96 | IN | denotes | with |
T29 | 97-110 | NN | denotes | moderate-dose |
T30 | 111-113 | IN | denotes | of |
T31 | 114-129 | NNS | denotes | corticosteroids |
T32 | 129-130 | -COMMA- | denotes | , |
T33 | 131-136 | MD | denotes | might |
T34 | 137-144 | VB | denotes | improve |
T35 | 145-152 | NN | denotes | patient |
T36 | 153-161 | NNS | denotes | outcomes |
T37 | 163-164 | PDT | denotes | • |
T38 | 166-169 | DT | denotes | The |
T39 | 170-173 | NN | denotes | use |
T40 | 174-176 | IN | denotes | of |
T41 | 177-192 | NNS | denotes | corticosteroids |
T42 | 193-198 | MD | denotes | might |
T43 | 199-209 | VB | denotes | accelerate |
R15 | T17 | T18 | arg1Of | Anti-antibodies,"," |
R16 | T19 | T18 | arg2Of | immunoglobulins,"," |
R17 | T21 | T20 | arg1Of | and,"," |
R18 | T18 | T21 | arg1Of | ",",and |
R19 | T22 | T21 | arg2Of | corticosteroids,and |
R20 | T25 | T24 | arg1Of | IVIG,• |
R21 | T25 | T26 | arg1Of | IVIG,"," |
R22 | T25 | T27 | arg2Of | IVIG,combined |
R23 | T27 | T28 | arg1Of | combined,with |
R24 | T29 | T28 | arg2Of | moderate-dose,with |
R25 | T29 | T30 | arg1Of | moderate-dose,of |
R26 | T31 | T30 | arg2Of | corticosteroids,of |
R27 | T34 | T32 | arg1Of | improve,"," |
R28 | T25 | T33 | arg1Of | IVIG,might |
R29 | T34 | T33 | arg2Of | improve,might |
R30 | T25 | T34 | arg1Of | IVIG,improve |
R31 | T36 | T34 | arg2Of | outcomes,improve |
R32 | T36 | T35 | arg1Of | outcomes,patient |
R33 | T39 | T37 | arg1Of | use,• |
R34 | T39 | T38 | arg1Of | use,The |
R35 | T39 | T40 | arg1Of | use,of |
R36 | T41 | T40 | arg2Of | corticosteroids,of |
R37 | T39 | T42 | arg1Of | use,might |
R38 | T43 | T42 | arg2Of | accelerate,might |
R39 | T39 | T43 | arg1Of | use,accelerate |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 25-40 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 8-61 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
T4 | 63-73 | Sentence | denotes | Highlights |
T5 | 74-162 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |